Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CCR7 | 5 | 2022 | 11 | 2.110 |
Why?
|
| Type C Phospholipases | 2 | 2020 | 21 | 1.130 |
Why?
|
| Chemokine CCL21 | 3 | 2012 | 11 | 0.810 |
Why?
|
| Chemokines, CC | 1 | 2022 | 51 | 0.800 |
Why?
|
| Chemokine CCL19 | 2 | 2012 | 5 | 0.750 |
Why?
|
| T-Lymphocytes | 4 | 2012 | 357 | 0.730 |
Why?
|
| Biological Products | 1 | 2021 | 71 | 0.730 |
Why?
|
| Antiviral Agents | 1 | 2021 | 157 | 0.720 |
Why?
|
| Arrestins | 5 | 2008 | 27 | 0.690 |
Why?
|
| Cell Degranulation | 2 | 2004 | 11 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2012 | 103 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2012 | 99 | 0.460 |
Why?
|
| Receptors, Formyl Peptide | 5 | 2005 | 5 | 0.430 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2012 | 4 | 0.420 |
Why?
|
| Chemotaxis | 3 | 2022 | 60 | 0.390 |
Why?
|
| Phospholipase C gamma | 1 | 2010 | 8 | 0.380 |
Why?
|
| Endocytosis | 3 | 2008 | 113 | 0.380 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1502 | 0.380 |
Why?
|
| Fibronectins | 1 | 2010 | 66 | 0.360 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 168 | 0.350 |
Why?
|
| Animals | 16 | 2021 | 15081 | 0.300 |
Why?
|
| Dendritic Cells | 3 | 2013 | 113 | 0.300 |
Why?
|
| Mast Cells | 2 | 2004 | 81 | 0.290 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2004 | 86 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1015 | 0.280 |
Why?
|
| Isoenzymes | 2 | 2020 | 161 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2015 | 8 | 0.240 |
Why?
|
| Phosphorylation | 6 | 2012 | 928 | 0.240 |
Why?
|
| Leukocytes | 1 | 2004 | 72 | 0.240 |
Why?
|
| Humans | 14 | 2022 | 37093 | 0.220 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2002 | 3 | 0.220 |
Why?
|
| Receptors, Peptide | 1 | 2002 | 23 | 0.220 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2014 | 54 | 0.220 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 61 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2014 | 308 | 0.210 |
Why?
|
| Lymph Nodes | 1 | 2022 | 67 | 0.200 |
Why?
|
| Immunity | 1 | 2021 | 53 | 0.200 |
Why?
|
| Peptides | 3 | 2014 | 320 | 0.200 |
Why?
|
| Mice | 8 | 2013 | 5913 | 0.190 |
Why?
|
| Signal Transduction | 7 | 2015 | 1908 | 0.180 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 204 | 0.180 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 9 | 0.180 |
Why?
|
| Lead Poisoning, Nervous System, Childhood | 1 | 2019 | 8 | 0.170 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 73 | 0.170 |
Why?
|
| Microglia | 1 | 2019 | 166 | 0.150 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1369 | 0.150 |
Why?
|
| Hyaluronic Acid | 2 | 2014 | 33 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 1609 | 0.150 |
Why?
|
| Immune Tolerance | 2 | 2014 | 65 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2014 | 1518 | 0.130 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cell Line | 3 | 2012 | 1354 | 0.130 |
Why?
|
| Hippocampus | 1 | 2019 | 561 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2015 | 53 | 0.130 |
Why?
|
| Transfection | 4 | 2004 | 523 | 0.130 |
Why?
|
| Keratinocytes | 1 | 2015 | 66 | 0.130 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2014 | 12 | 0.120 |
Why?
|
| Autoantigens | 1 | 2014 | 81 | 0.120 |
Why?
|
| Protein Binding | 3 | 2008 | 972 | 0.120 |
Why?
|
| Ovalbumin | 1 | 2013 | 47 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 1 | 2013 | 30 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 617 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 56 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2014 | 125 | 0.110 |
Why?
|
| Polymers | 1 | 2013 | 121 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 408 | 0.110 |
Why?
|
| Phosphatidylinositols | 1 | 2012 | 12 | 0.100 |
Why?
|
| Lysophospholipids | 1 | 2012 | 19 | 0.100 |
Why?
|
| Sphingosine | 1 | 2012 | 21 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 59 | 0.100 |
Why?
|
| Ligands | 3 | 2008 | 349 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2015 | 517 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 57 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 162 | 0.090 |
Why?
|
| Chemokines | 1 | 2010 | 97 | 0.090 |
Why?
|
| Nanostructures | 1 | 2011 | 134 | 0.080 |
Why?
|
| Receptor Aggregation | 1 | 2008 | 1 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2015 | 163 | 0.080 |
Why?
|
| Jurkat Cells | 1 | 2008 | 79 | 0.080 |
Why?
|
| Gene Expression | 1 | 2012 | 674 | 0.080 |
Why?
|
| Protein Transport | 3 | 2005 | 302 | 0.080 |
Why?
|
| Proteins | 1 | 2011 | 369 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2015 | 933 | 0.070 |
Why?
|
| Cell Movement | 1 | 2010 | 571 | 0.070 |
Why?
|
| Female | 3 | 2022 | 20969 | 0.070 |
Why?
|
| Arrestin | 2 | 2004 | 7 | 0.070 |
Why?
|
| HL-60 Cells | 2 | 2004 | 32 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 618 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 409 | 0.070 |
Why?
|
| Kinetics | 2 | 2005 | 708 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 47 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 252 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 132 | 0.050 |
Why?
|
| Time Factors | 3 | 2019 | 1742 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2231 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 502 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 602 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 29 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 40 | 0.040 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 202 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2019 | 343 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 435 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1398 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 439 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 31 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 3483 | 0.030 |
Why?
|
| U937 Cells | 2 | 2005 | 27 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 116 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 118 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2015 | 174 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 218 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 199 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2005 | 208 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 190 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 178 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 159 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 59 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2013 | 159 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 236 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 448 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2011 | 1 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2011 | 212 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1198 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 288 | 0.020 |
Why?
|
| Quinolinium Compounds | 1 | 2005 | 7 | 0.020 |
Why?
|
| Point Mutation | 1 | 2005 | 93 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2004 | 26 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 19 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2004 | 30 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 53 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 60 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 106 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 191 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 181 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 1346 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 208 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 147 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 295 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 207 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 307 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 389 | 0.010 |
Why?
|
| Cholesterol | 1 | 2004 | 205 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 267 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 444 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 235 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 272 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 381 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1180 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 480 | 0.010 |
Why?
|
| Male | 1 | 2019 | 20025 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 487 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 1095 | 0.010 |
Why?
|